NIOX Group Plc (AIM: NIOX)

Market Cap	253.12M
Revenue (ttm)	39.00M
Net Income (ttm)	11.70M
Shares Out	397.98M
EPS (ttm)	0.03
PE Ratio	26.09
Forward PE	24.93
Dividend	0.01 (1.57%)
Ex-Dividend Date	May 23, 2024

Volume	27,132
Average Volume	612,258
Open	62.20
Previous Close	63.60
Day's Range	62.20 - 63.00
52-Week Range	57.20 - 80.00
Beta	0.96
RSI	56.95
Earnings Date	Dec 24, 2024

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2006
• Employees: 92
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2023, NIOX Group's revenue was 36.80 million, an increase of 17.57% compared to the previous year's 31.30 million. Earnings were 10.70 million, a decrease of -33.54%.